Banu S. Zolnik

2.7k total citations · 1 hit paper
19 papers, 2.1k citations indexed

About

Banu S. Zolnik is a scholar working on Pharmaceutical Science, Materials Chemistry and Biomaterials. According to data from OpenAlex, Banu S. Zolnik has authored 19 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 6 papers in Materials Chemistry and 5 papers in Biomaterials. Recurrent topics in Banu S. Zolnik's work include Drug Solubulity and Delivery Systems (6 papers), Advanced Drug Delivery Systems (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Banu S. Zolnik is often cited by papers focused on Drug Solubulity and Delivery Systems (6 papers), Advanced Drug Delivery Systems (6 papers) and Nanoparticle-Based Drug Delivery (4 papers). Banu S. Zolnik collaborates with scholars based in United States and Spain. Banu S. Zolnik's co-authors include Diane J. Burgess, Nakissa Sadrieh, África González‐Fernández, Marina A. Dobrovolskaia, Pauline E. Leary, Stęphan T. Stern, Jeffrey D. Clogston, Scott E. McNeil, Christopher B. McLeland and Jiwen Zheng and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Cancer Research and Endocrinology.

In The Last Decade

Banu S. Zolnik

19 papers receiving 2.1k citations

Hit Papers

Minireview: Nanoparticles and the Immune System 2009 2026 2014 2020 2009 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Banu S. Zolnik United States 14 738 687 576 547 429 19 2.1k
Rishi Paliwal India 26 951 1.3× 992 1.4× 626 1.1× 924 1.7× 246 0.6× 63 2.9k
Munira Momin India 24 557 0.8× 500 0.7× 585 1.0× 924 1.7× 216 0.5× 85 2.7k
Mengrui Liu China 24 624 0.8× 377 0.5× 749 1.3× 817 1.5× 258 0.6× 42 2.4k
Fiorenza Rancan Germany 29 519 0.7× 775 1.1× 573 1.0× 461 0.8× 709 1.7× 72 2.8k
Monica Argenziano Italy 30 769 1.0× 375 0.5× 785 1.4× 521 1.0× 331 0.8× 86 2.3k
Shiyan Guo China 23 830 1.1× 677 1.0× 582 1.0× 816 1.5× 371 0.9× 52 2.2k
Arnaud Béduneau France 25 716 1.0× 634 0.9× 404 0.7× 629 1.1× 240 0.6× 58 2.0k
Bhuvaneshwar Vaidya India 33 786 1.1× 899 1.3× 726 1.3× 955 1.7× 682 1.6× 64 3.4k
Sarah Hedtrich Germany 37 695 0.9× 1.2k 1.8× 657 1.1× 912 1.7× 209 0.5× 101 3.7k
Ali Mohammad Tamaddon Iran 30 812 1.1× 389 0.6× 636 1.1× 948 1.7× 509 1.2× 153 2.9k

Countries citing papers authored by Banu S. Zolnik

Since Specialization
Citations

This map shows the geographic impact of Banu S. Zolnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banu S. Zolnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banu S. Zolnik more than expected).

Fields of papers citing papers by Banu S. Zolnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banu S. Zolnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banu S. Zolnik. The network helps show where Banu S. Zolnik may publish in the future.

Co-authorship network of co-authors of Banu S. Zolnik

This figure shows the co-authorship network connecting the top 25 collaborators of Banu S. Zolnik. A scholar is included among the top collaborators of Banu S. Zolnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banu S. Zolnik. Banu S. Zolnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Barbato, Michael I., Diana Bradford, Yi Ren, et al.. (2023). FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation–Positive Low-Grade Glioma. Clinical Cancer Research. 30(2). 263–268. 33 indexed citations
2.
Wu, Fang, Kimberly Raines, Rodrigo Cristofoletti, et al.. (2022). Regulatory utility of physiologically‐based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report. CPT Pharmacometrics & Systems Pharmacology. 12(5). 585–597. 16 indexed citations
3.
Bai, Ge, et al.. (2019). Assessment of Applications of Design of Experiments in Pharmaceutical Development for Oral Solid Dosage Forms. Journal of Pharmaceutical Innovation. 15(4). 547–555. 3 indexed citations
4.
Kumar, Sumit, Jie Shen, Banu S. Zolnik, Nakissa Sadrieh, & Diane J. Burgess. (2015). Optimization and dissolution performance of spray-dried naproxen nano-crystals. International Journal of Pharmaceutics. 486(1-2). 159–166. 27 indexed citations
5.
Finch, Gregory L., Henry A. Havel, Mostafa Analoui, et al.. (2014). Nanomedicine Drug Development: A Scientific Symposium Entitled “Charting a Roadmap to Commercialization”. The AAPS Journal. 16(4). 698–704. 12 indexed citations
6.
Kumar, Sumit, Rajan Jog, Jie Shen, et al.. (2014). In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole. Journal of Pharmaceutical Sciences. 104(9). 3018–3028. 31 indexed citations
7.
Kumar, Sumit, Rajan Jog, Jie Shen, et al.. (2014). Formulation and Performance of Danazol Nano-crystalline Suspensions and Spray Dried Powders. Pharmaceutical Research. 32(5). 1694–1703. 21 indexed citations
8.
Zolnik, Banu S., Timothy M. Potter, & Stęphan T. Stern. (2010). Detecting Reactive Oxygen Species in Primary Hepatocytes Treated with Nanoparticles. Methods in molecular biology. 697. 173–179. 6 indexed citations
9.
Zolnik, Banu S. & Nakissa Sadrieh. (2009). Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs. Advanced Drug Delivery Reviews. 61(6). 422–427. 85 indexed citations
10.
Zolnik, Banu S., África González‐Fernández, Nakissa Sadrieh, & Marina A. Dobrovolskaia. (2009). Minireview: Nanoparticles and the Immune System. Endocrinology. 151(2). 458–465. 704 indexed citations breakdown →
11.
Zolnik, Banu S., Stęphan T. Stern, James M. Kaiser, et al.. (2008). Rapid Distribution of Liposomal Short-Chain Ceramide in Vitro and in Vivo. Drug Metabolism and Disposition. 36(8). 1709–1715. 62 indexed citations
12.
Zolnik, Banu S. & Diane J. Burgess. (2008). Evaluation of in vivo–in vitro release of dexamethasone from PLGA microspheres. Journal of Controlled Release. 127(2). 137–145. 245 indexed citations
13.
Stern, Stęphan T., Banu S. Zolnik, Christopher B. McLeland, et al.. (2008). Induction of Autophagy in Porcine Kidney Cells by Quantum Dots: A Common Cellular Response to Nanomaterials?. Toxicological Sciences. 106(1). 140–152. 151 indexed citations
14.
Zolnik, Banu S., et al.. (2008). In situ fiber optic method for long-term in vitro release testing of microspheres. International Journal of Pharmaceutics. 356(1-2). 206–211. 18 indexed citations
15.
Zolnik, Banu S. & Diane J. Burgess. (2007). Effect of acidic pH on PLGA microsphere degradation and release. Journal of Controlled Release. 122(3). 338–344. 448 indexed citations
16.
Zolnik, Banu S., Pauline E. Leary, & Diane J. Burgess. (2006). Elevated temperature accelerated release testing of PLGA microspheres. Journal of Controlled Release. 112(3). 293–300. 198 indexed citations
17.
Zolnik, Banu S., et al.. (2005). Application of USP Apparatus 4 and In Situ Fiber Optic Analysis to Microsphere Release Testing. Dissolution Technologies. 12(2). 11–14. 63 indexed citations
18.
Zolnik, Banu S.. (2005). In vitro and in vivo release testing of controlled release parenteral microspheres. OpenCommons - UConn (University of Connecticut). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026